Get answers for your health queries from top Doctors for FREE!

100% Privacy Protection

100% Privacy Protection

We maintain your privacy and data confidentiality.

Verified Doctors

Verified Doctors

All Doctors go through a stringent verification process.

Quick Response

Quick Response

All Doctors go through a stringent verification process.

Reduce Clinic Visits

Reduce Clinic Visits

Save your time and money from the hassle of visits.

Ask Free Question

  1. Home >
  2. Blogs >
  3. squamous cell carcinoma in thyroid
  • Cancer

squamous cell carcinoma in thyroid

By Ipshita Ghoshal| Last Updated at: 29th Apr '24| 16 Min Read

Squamous cell carcinoma in the thyroid is a rare and aggressive form of thyroid cancer. It accounts for only 1% of cancers in the thyroid. It differs from other thyroid cancers, like follicular or papillary cancers. They develop from different kinds of cancers. But, squamous cell carcinoma in the thyroid is different. It originates from squamous cells, which are flat and thin in structure. It occurs as a fast-growing lump in the neck. It can also spread to nearby tissues and other parts of the body. Squamous cell carcinoma in the thyroid is more common in people over 50. Also, it affects females more often than men. 

This type of cancer is known for its rapid progression and poor prognosis. Symptoms may include:

  • A fast-growing neck mass.
  • Pain.
  • Difficulty swallowing.
  • Changes in voice.
  • Possibly symptoms of local invasion such as coughing or difficulty breathing.

Genetic Factors Contributing to Thyroid Squamous Cell Carcinoma

Cancers in the thyroid gland are prevalent. But, specifically squamous cell carcinoma is not very common. But still, some genetic reasons can cause carcinoma in the thyroid gland. Specific genes control the signals in our cells, and sometimes they may change. When this happens, there is a disruption of balance between cell growth and cell death. This leads to the development of tumors. Hence, it leads to squamous cell carcinoma in the thyroid or other types of cancers in the thyroid. 

Curious about what might increase the risk? Let's explore the factors linked to thyroid squamous cell carcinoma.

What Are the Risk Factors Associated with Thyroid Squamous Cell Carcinoma?

Squamous cell carcinoma in the thyroid is a very rare type of cancer. The common risk factors associated with this are: 

  • Risk increases with age: Squamous cell carcinoma is often diagnosed in people above 50 years of age. 
  • This risk of thyroid squamous cell carcinoma is more common in females. 
  • Exposure to high levels of radiation increases the risk. This can be from medical treatments like radiation therapy or environmental exposure. 
  • Family history may be a risk factor. Certain genetic factors play a role. 
  • Iodine is essential for proper thyroid function. Both deficiency and excess of iodine can increase the risk of carcinoma in the thyroid. 
  • Some genetic conditions can increase the risk, like familial medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2). 
  • Some benign (non-cancerous) thyroid conditions like goitre or thyroid nodules can also be a risk factor.

How is Squamous Cell Carcinoma in Thyroid Identified?

Identifying squamous cell carcinoma in the thyroid involves a combination of medical examinations and diagnostic tests. Here is how it is identified:

  • Clinical evaluation by doctor: They do a physical examination and check for any lumps or abnormalities in the neck. 
  • Imaging tests: Ultrasound, CT, or MRI to visualize the thyroid and surrounding tissues.
  • Fine Needle Aspiration (FNA): A thin needle is used to withdraw cells for analysis.
  • Histological Examination:  Analyzing the tissue sample for squamous cell carcinoma characteristics.

Treatment Options

Treatment options for squamous cell carcinoma in the thyroid may include:

  • Surgery: It means the removal of the tumour. Sometimes a portion or the entire thyroid gland may be removed.
  • Radiotherapy: Using high-dose radiation to target and destroy cancer cells.
  • Chemotherapy: Administering drugs to kill cancer cells or slow their growth.
  • Targeted Therapy: Using drugs that specifically target cancer cells. And also minimize damage to normal cells.
  • Immunotherapy: Stimulating the body's immune system to recognize and attack cancer cells.

The results and outcomes of the treatment may vary. It is based on certain factors like stage, extent and overall health. You must regularly follow up with your doctor regarding your progress and make adjustments if necessary. Adhere to instructions given by your doctor and make necessary changes in your lifestyle. 





FAQs:

Q1. Can Squamous Cell Carcinoma Spread to Other Organs?

Ans. Yes, squamous cell carcinoma can spread to other organs. The likelihood of spread depends on various factors. Such as the stage of cancer and how early it is detected. 

Q2. What is the Long-term Prognosis for Patients with Squamous Cell Carcinoma in Thyroid?

Ans. Early detection of squamous cell carcinoma in the thyroid can increase the chances of survival for five years after the treatment. 

Related Blogs

Question and Answers

Hello Doctor, good evening. I am Lokesh, and I am taking care of my grandmother at home. She has stage 4 cervical cancer, and we are currently focusing on palliative care. Unfortunately, we do not have regular access to a nearby doctor or hospital, so I’m managing everything myself at home. I’m doing my best to support her with love, comfort, and the correct medicines. She has been experiencing: Pain (sometimes mild, sometimes strong) Lack of sleep or restlessness Occasional constipation and vomiting feeling I have some medicines like: Tramadol 50 mg Paracetamol 650 mg Lorazepam 1 mg Pan 40 Ondansetron 4 mg Lactulose syrup Based on her condition, I would like to know: 1. When and how to use Tramadol or Paracetamol for pain. Can they be used together? 2. Is Lorazepam safe to give daily? Should I reduce it slowly if I stop? 3. What are the risks if I stop Tramadol or Lorazepam suddenly? 4. Can I use Ondansetron only when vomiting starts? Or daily? 5. How often should I give Lactulose syrup if there’s no bowel movement? 6. Do you recommend any vitamins or supportive care for comfort or strength? 7. If she is calm and has no symptoms, can I skip some medicines? I want to provide her full comfort, dignity, and peace. Kindly guide me with the best possible medicine routine and precautions I should follow at home.

Female | 68

Answered on 10th June '25

Read answer

. Heterogeneous Soft Tissue Nodule in the Right Lower Lobe (RLL) Size: 14 x 8 mm This nodule is described as heterogeneously enhancing, which suggests it may have varying levels of blood flow or different tissue densities within it. This could be indicative of a tumor. 2. Air Space Opacification in the Right Upper Lobe (RUL) Finding: There is patchy air space opacification with interlobular septal thickening in the posterior segment of RUL. This could represent infection, inflammation, or more concerningly, metastatic disease or lung cancer causing these changes. 3. Left-sided Pleural Effusion and Subsegmental Atelectasis Pleural Effusion: Mild left-sided pleural effusion is noted. Pleural effusion can occur in the context of metastatic disease or cancer. Atelectasis: This refers to partial lung collapse, which may occur when there is a mass obstructing the airflow or due to pleural fluid. 4. Enlarged Mediastinal and Hilar Lymph Nodes Lymphadenopathy: There are multiple enlarged and necrotic lymph nodes, most notably in the right hilar region, with the largest measuring 35 x 25 mm. Enlargement and necrosis of lymph nodes can be a sign of metastatic spread. The presence of enlarged lymph nodes in the mediastinum and hilum is typical of malignancy spreading beyond the primary lung site. 5. Liver Lesion Size: 14 x 13 mm lesion in the right hepatic lobe, which is well-defined and peripherally enhancing. A hypodense lesion could indicate a metastatic tumor, especially since it shows peripheral enhancement, a characteristic of some types of metastases. 6. Skeletal Lesions Multiple Lesions: There are mixed lytic and sclerotic bony lesions, some with soft tissue components. These lesions involve the vertebrae, ribs, glenoids, sternum, sacral ala, iliac bones, and femur. Soft Tissue Components: Some of the lesions, such as those in the ribs and iliac bones, have a soft tissue component, which suggests more advanced involvement, possibly indicating metastases. 7. Other Findings: No signs of emphysema, bronchiectasis, or pneumothorax were noted, which is reassuring as it reduces the likelihood of certain types of lung diseases. The liver, spleen, pancreas, kidneys, urinary bladder, and prostate all appear normal on imaging, which helps to rule out major issues in these organs. Impression: The findings of a heterogeneously enhancing solitary pulmonary nodule in the right lung, with associated hilar and mediastinal lymphadenopathy, along with a hepatic lesion and extensive skeletal involvement (with mixed lytic and sclerotic lesions), strongly raise concern for metastatic disease, most likely originating from the lung. The primary lung cancer is a potential consideration, though other primary sites are also possible. Next Steps: Histopathological correlation: This means a biopsy or tissue sample should be taken from one of the lesions (pulmonary, hepatic, or bone) to confirm whether the lesions are malignant and, if so, to identify the type of cancer. This will help determine the best course of treatment. The overall picture suggests a metastatic malignancy, likely of pulmonary origin, but further investigations and biopsy are essential to establish a definitive diagnosis and treatment plan.

Male | 58

Answered on 8th Mar '25

Read answer

Cancer Hospitals In Other Cities

Top Related Speciality Doctors In Other Cities

Cost Of Related Treatments In Country

Consult